abstract |
The invention relates to a phenyl-substituted dihydronaphthyridine compound and application thereof, and further relates to a pharmaceutical composition containing the compound. The compounds of the invention or the pharmaceutical compositions may be used as mineralocorticoid receptor antagonists. |